Pfizer Oncology Survey: 10% Of Japanese Lung Cancer Patients Underwent Genetic Testing
This article was originally published in PharmAsia News
Executive Summary
Ten percent of Japanese patients underwent genetic testing when selecting drug treatment for lung cancer, according to a Pfizer Japan Oncology Unit survey.